Efficacy of a Special Oral Nutritional Supplement on Nutritional Status of Malnourished Elderly Patients (Nutri-PA)
Primary Purpose
Malnutrition
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Nutri-Energie ®, Aliscience society
Clinutren 1.5 ®, Nestlé Clinical Nutrition
Sponsored by
About this trial
This is an interventional supportive care trial for Malnutrition focused on measuring elderly patient, malnutrition, new nutritional support, micronutrients, elderly patient malnutrition
Eligibility Criteria
Inclusion Criteria:
- Both male and female participants
Moderately malnourished defined by whether:
18 < BMI < 21
5 to 10% body weight loss in the last past 6 months.
Buzby index between 83.5 and 97.5 (calculated with weight loss and albumin)
- With or without any factors increasing malnutrition (insufficient caloric intakes, long term treatment)
- Justifying hospitalisation in rehabilitation unit
Exclusion Criteria:
- Age < 70 years old or > 90 years old
- Surgical affection involving a surgery in the next 10 days
- Contraindicated oral intakes due to digestive injury
- Total parenteral nutrition
- Ulcer or infection existing
- Malignant hemopathy
- Hepatic insufficiency (TP < 30%)
- Swallowing difficulties limiting solid oral intakes
- Kidney failure (renal dialysis)
- Expected survival > 3 months
- Impossibility to give an informed consent
Sites / Locations
- Centre Hospitalier de Dieppe
- UHRouen
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
1
2
Arm Description
Nutri-Energie ®, a cake of high caloric density and palatability, twice a day for 4 weeks, in addition to an enriched diet.
Clinutren 1.5 ® standard isocaloric commercially available supplement, twice a day for 4 weeks, in addition to an enriched diet.
Outcomes
Primary Outcome Measures
outcome of fat-free mass measured by multiple frequence bio-impedance analysis
Secondary Outcome Measures
safety of oral supplementation
Full Information
NCT ID
NCT00877578
First Posted
April 7, 2009
Last Updated
October 15, 2013
Sponsor
University Hospital, Rouen
1. Study Identification
Unique Protocol Identification Number
NCT00877578
Brief Title
Efficacy of a Special Oral Nutritional Supplement on Nutritional Status of Malnourished Elderly Patients
Acronym
Nutri-PA
Official Title
Efficacy of a Special Oral Nutritional Supplement on Nutritional Status of Malnourished Elderly Patients
Study Type
Interventional
2. Study Status
Record Verification Date
October 2013
Overall Recruitment Status
Completed
Study Start Date
April 2009 (undefined)
Primary Completion Date
July 2011 (Actual)
Study Completion Date
July 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Rouen
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to evaluate in malnourished elderly patients the nutritional efficacy of a new nutritional supplement enriched in different specific pharmaco nutrients (leucine, micronutrients, omega-3) appearing in the form of a cake of high caloric density and palatability.
The primary endpoint is the outcome of fat-free mass measured by multiple frequence bio-impedance analysis.
Detailed Description
Ageing of the population and loss of autonomy expose to major consequences in terms of treatment charges and need for hospitalisation. Malnutrition has a key prognostic value, that worsen the prognosis of the primary disease; the length of hospital stay and the incidence of complications are related to nutritional status (Correia 2003, Pichard 2004, Schneider 2004). Several large scale studies at Rouen University Hospital, in 1998 and 2001, have revealed on more than 1000 patients (mid age 71 years) that malnutrition prevalence ranged of 35 to 38%, one third of which is severe (Jusserand 2000, Delaire 2002). Malnutrition increases the risk of complications (Naber 1997, Correia 2003), including muscle mass depletion, decrease of immune function and delayed wound healing. The main consequence of malnutrition is increased infectious morbidity and post operative mortality for the weakest patients. Increased length of hospital stay and rehabilitation duration also results in increased medicals and social burden, in particular in the elderly patients.
Recent studies have shown that usual hospital food intake was insufficient to cover patient's needs (Hébuterne 2001, Dupertuis 2003, Petit 2004) and that systematic nutritional screening was mandatory in hospitalised patients, using validated criteria and scales (e.g. NutriSteps®, MNA®).
The strategy for nutritional support includes as a first step enriched diets and the use of oral supplements, then enteral nutrition or even parenteral nutrition in the most severe cases (HAS guidelines 2007). The efficacy of oral supplementation has been proven (Stratton 2007). Yet, their composition still need to be optimised to better match specific nutritional needs and to ameliorate palatability and favour compliance.
The provision of specifics nutrients with anabolic, anti-oxidants or anti-inflammatory effects can optimise oral nutritional supplements, to achieve a true pharmaco-nutritional therapy. Accordingly, leucine enrichment has inhibitory effects on proteasome-mediated muscular proteolysis in aged rats (Combaret 2005). Trace elements deficiency (zinc, selenium, chromium, iron) is common in the elderly patients and increase the risk of infectious or wound complications (HAS 2007), and the level of trace elements provision in standard supplements may be insufficient to compensate this deficiency. Finally, omega-3 fatty acids enrichment enables to limit the inflammatory response and hypercatabolism (Delarue 2005).
The aim of this study is to evaluate in malnourished elderly patients the nutritional efficacy of a new nutritional supplement enriched in different specific pharmaco nutrients (leucine, micronutrients, omega-3) appearing in the form of a cake of high caloric density and palatability.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malnutrition
Keywords
elderly patient, malnutrition, new nutritional support, micronutrients, elderly patient malnutrition
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Nutri-Energie ®, a cake of high caloric density and palatability, twice a day for 4 weeks, in addition to an enriched diet.
Arm Title
2
Arm Type
Active Comparator
Arm Description
Clinutren 1.5 ® standard isocaloric commercially available supplement, twice a day for 4 weeks, in addition to an enriched diet.
Intervention Type
Dietary Supplement
Intervention Name(s)
Nutri-Energie ®, Aliscience society
Intervention Description
Nutri-Energie ® is a new cake of high caloric density and palatability, enriched in different specific pharmaco nutrients.
Intervention Type
Dietary Supplement
Intervention Name(s)
Clinutren 1.5 ®, Nestlé Clinical Nutrition
Intervention Description
Clinutren 1.5 ®, isocaloric commercially available supplement, twice a day for 4 weeks, in addition to an enriched diet
Primary Outcome Measure Information:
Title
outcome of fat-free mass measured by multiple frequence bio-impedance analysis
Time Frame
28 days
Secondary Outcome Measure Information:
Title
safety of oral supplementation
Time Frame
28 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
95 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Both male and female participants
Moderately malnourished defined by whether:
18 < BMI < 21
5 to 10% body weight loss in the last past 6 months.
Buzby index between 83.5 and 97.5 (calculated with weight loss and albumin)
With or without any factors increasing malnutrition (insufficient caloric intakes, long term treatment)
Justifying hospitalisation in rehabilitation unit
Exclusion Criteria:
Age < 70 years old or > 90 years old
Surgical affection involving a surgery in the next 10 days
Contraindicated oral intakes due to digestive injury
Total parenteral nutrition
Ulcer or infection existing
Malignant hemopathy
Hepatic insufficiency (TP < 30%)
Swallowing difficulties limiting solid oral intakes
Kidney failure (renal dialysis)
Expected survival > 3 months
Impossibility to give an informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pierre DECHELOTTE, PR
Organizational Affiliation
University Hospital, Rouen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Hospitalier de Dieppe
City
Dieppe
ZIP/Postal Code
76200
Country
France
Facility Name
UHRouen
City
Rouen
ZIP/Postal Code
76031
Country
France
12. IPD Sharing Statement
Learn more about this trial
Efficacy of a Special Oral Nutritional Supplement on Nutritional Status of Malnourished Elderly Patients
We'll reach out to this number within 24 hrs